Cefiderocol sulfate tosylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cefiderocol sulfate tosylate and what is the scope of freedom to operate?
Cefiderocol sulfate tosylate
is the generic ingredient in one branded drug marketed by Shionogi Inc and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Cefiderocol sulfate tosylate has eighty-two patent family members in thirty-eight countries.
One supplier is listed for this compound.
Summary for cefiderocol sulfate tosylate
International Patents: | 82 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 20 |
Patent Applications: | 1 |
What excipients (inactive ingredients) are in cefiderocol sulfate tosylate? | cefiderocol sulfate tosylate excipients list |
DailyMed Link: | cefiderocol sulfate tosylate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for cefiderocol sulfate tosylate
Generic Entry Date for cefiderocol sulfate tosylate*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for cefiderocol sulfate tosylate
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for cefiderocol sulfate tosylate
US Patents and Regulatory Information for cefiderocol sulfate tosylate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shionogi Inc | FETROJA | cefiderocol sulfate tosylate | POWDER;INTRAVENOUS | 209445-001 | Nov 14, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for cefiderocol sulfate tosylate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 3190115 | ⤷ Try a Trial | |
Poland | 2960244 | ⤷ Try a Trial | |
Mexico | 2017002790 | SAL DE UN DERIVADO DE CEFALOSPORINA, FORMA SOLIDA CRISTALINA DEL MISMO Y METODO PARA SU PRODUCCION. (SALT OF CEPHALOSPORIN DERIVATIVE, CRYSTALLINE SOLID FORM OF SAME AND METHOD FOR PRODUCING SAME.) | ⤷ Try a Trial |
European Patent Office | 3189841 | PRÉPARATION PHARMACEUTIQUE COMPRENANT UNE CÉPHALOSPORINE AYANT DES GROUPES CATÉCHOL (PHARMACEUTICAL PREPARATION COMPRISING CEPHALOSPORIN HAVING CATECHOL GROUPS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for cefiderocol sulfate tosylate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2960244 | 2020C/541 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, OPTIONEEL IN DE VORM VAN EEN FARMACEUTISCH ZOUT OF SOLVAAT; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424 |
2960244 | LUC00179 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, EVENTUELLEMENT SOUS LA FORME D'UN SEL OU D'UN SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE; AUTHORISATION NUMBER AND DATE: EU/1/20/1434 20200424 |
2960244 | CA 2020 00049 | Denmark | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT; REG. NO/DATE: EU/1/20/1434 20200424 |
2960244 | 122020000060 | Germany | ⤷ Try a Trial | PRODUCT NAME: CEFIDEROCOL; REGISTRATION NO/DATE: EU/1/20/1434 20200423 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.